Ouster, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Ouster, Inc. on April 17, 2023. The filing addresses a notice of noncompliance with New York Stock Exchange (NYSE) continued listing standards and the Company's plan to cure this deficiency through a reverse stock split.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, or debt metrics. The only financial metric disclosed is the stock price deficiency triggering the listing review: the average closing price of the Company's common stock was less than $1.00 over a consecutive 30 trading-day period.
Material Changes and Events
- NYSE Noncompliance Notice: On April 12, 2023, the Company received notification from the NYSE that it failed to meet Section 802.01C of the Listed Company Manual due to the stock price falling below the $1.00 minimum threshold.
- Reverse Stock Split Approval: The Board of Directors previously approved a one-for-10 reverse stock split and a reduction in authorized shares on April 7, 2023.
- Trading Adjustment: The Company expects the reverse stock split to begin trading on a split-adjusted basis on April 21, 2023.
Outlook, Risks, and Management Commentary
Management intends to use the reverse stock split to cure the stock price deficiency and regain compliance with NYSE standards. The Company has a six-month cure period from the date of the notification to achieve a closing share price of at least $1.00 and an average closing price of at least $1.00 over a 30-day period. The Company expects its common stock to continue trading on the NYSE during this period, subject to compliance with other listing standards. The filing includes standard forward-looking statement disclaimers regarding the uncertainty of regaining compliance and future performance.
Investor Verification Checklist
- Confirm the effective date and trading start time of the one-for-10 reverse stock split (expected April 21, 2023).
- Monitor the post-split stock price to ensure it meets the $1.00 minimum threshold required for NYSE compliance.
- Verify the status of the Company's compliance with other NYSE continued listing standards beyond the stock price requirement.
- Review the Company's most recent Form 10-K for detailed risk factors and financial position, as this 8-K does not provide financial data.